Breaking News

Japan Industrial Production Falls 3.3% in June, More Than Estimated
Tweet TWEET

Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results

Tekmira Conference Call and Webcast Advisory: Corporate Update and First
Quarter Financial Results

VANCOUVER, British Columbia, May 9, 2013 (GLOBE NEWSWIRE) -- Tekmira
Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of
RNA interference (RNAi) therapeutics, announced that it will hold a conference
call and webcast on Tuesday, May 14, 2013 at 1:00 pm Pacific Time (4:00 pm
Eastern Time) to provide a corporate update and report financial results for
the first quarter ended March 31, 2013.

Conference Call and Webcast Information

A live webcast of the call can be accessed through the Investor section of
Tekmira's website at www.tekmirapharm.com. Or, alternatively, to access the
conference call, please dial 914-495-8556 or 1-866-393-1607.

An archived webcast will be available on the Tekmira website approximately two
hours after the event. Alternatively, you may access a replay of the
conference call by calling 404-537-3406 or 1-855-859-2056 and referencing
conference ID 69658053.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on
advancing novel RNAi therapeutics and providing its leading lipid nanoparticle
delivery technology to pharmaceutical partners. Tekmira has been working in
the field of nucleic acid delivery for over a decade and has broad
intellectual property covering LNPs. Further information about Tekmira can be
found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

CONTACT: Investors
         Jodi Regts
         Director, Investor Relations
         Phone: 604-419-3234
         Email: jregts@tekmirapharm.com
        
         Media
         David Ryan
         Longview Communications Inc.
         Phone: 416-649-8007
         Email: dryan@longviewcomms.ca

Tekmira Pharmaceuticals Logo